NOTV Stock Overview
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Inotiv, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.25 |
| 52 Week High | US$42.63 |
| 52 Week Low | US$3.65 |
| Beta | 2.53 |
| 1 Month Change | 46.76% |
| 3 Month Change | -60.38% |
| 1 Year Change | -78.18% |
| 3 Year Change | 46.17% |
| 5 Year Change | 269.90% |
| Change since IPO | -12.12% |
Recent News & Updates
Recent updates
We Think Inotiv (NASDAQ:NOTV) Has A Fair Chunk Of Debt
Dec 08
Calculating The Intrinsic Value Of Inotiv, Inc. (NASDAQ:NOTV)
Nov 17Does Inotiv (NASDAQ:NOTV) Have A Healthy Balance Sheet?
Sep 02One Analyst's Revenue Estimates For Inotiv, Inc. (NASDAQ:NOTV) Are Surging Higher
May 04Insider Buying: The Bioanalytical Systems, Inc. (NASDAQ:BASI) President Just Bought 2.2% More Shares
Feb 25Market Sentiment Around Loss-Making Bioanalytical Systems, Inc. (NASDAQ:BASI)
Feb 09The Bioanalytical Systems (NASDAQ:BASI) Share Price Has Soared 913%, Delighting Many Shareholders
Jan 19
Here's What Bioanalytical Systems, Inc.'s (NASDAQ:BASI) Shareholder Ownership Structure Looks Like
Dec 25How Much Are Bioanalytical Systems, Inc. (NASDAQ:BASI) Insiders Spending On Buying Shares?
Dec 04Shareholder Returns
| NOTV | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 6.3% | -2.2% | 0.2% |
| 1Y | -78.2% | -14.5% | -13.6% |
Return vs Industry: NOTV underperformed the US Life Sciences industry which returned -14.5% over the past year.
Return vs Market: NOTV underperformed the US Market which returned -13.6% over the past year.
Price Volatility
| NOTV volatility | |
|---|---|
| NOTV Average Weekly Movement | 25.8% |
| Life Sciences Industry Average Movement | 11.7% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: NOTV is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 26% a week.
Volatility Over Time: NOTV's weekly volatility has increased from 18% to 26% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 2,152 | Bob Leasure | https://www.inotivco.com |
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment, Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company’s BASi product line.
Inotiv, Inc. Fundamentals Summary
| NOTV fundamental statistics | |
|---|---|
| Market Cap | US$185.76m |
| Earnings (TTM) | -US$337.02m |
| Revenue (TTM) | US$547.66m |
0.3x
P/S Ratio-0.6x
P/E RatioIs NOTV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NOTV income statement (TTM) | |
|---|---|
| Revenue | US$547.66m |
| Cost of Revenue | US$390.44m |
| Gross Profit | US$157.21m |
| Other Expenses | US$494.23m |
| Earnings | -US$337.02m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -13.15 |
| Gross Margin | 28.71% |
| Net Profit Margin | -61.54% |
| Debt/Equity Ratio | 98.3% |
How did NOTV perform over the long term?
See historical performance and comparison